Publikationen, an denen er mitarbeitet Eva González-Haba Peña (5)

2022

  1. A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application

    Frontiers in Oncology, Vol. 12

2021

  1. Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

    Scientific Reports, Vol. 11, Núm. 1

  2. Aggressiveness of end-of-life cancer care: what happens in clinical practice?

    Supportive Care in Cancer, Vol. 29, Núm. 6, pp. 3121-3127

  3. Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice

    Supportive Care in Cancer, Vol. 29, Núm. 8, pp. 4673-4681

2018

  1. Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene

    Cancer Management and Research, Vol. 10, pp. 4517-4522